Furthermore, Stat5 is constitutively active in many forms of hematologic cancers [5], and, aside Bcr-Abl, it is a signaling hallmark of CML and its activity is associated with poor prognosis [7]. The gene discussed is STAT5B; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.